BioSyent Signs Exclusive Distribution Agreement for Two New Cardiovascular Products
May 25, 2016 12:53 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - May 25, 2016) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that its subsidiary BioSyent Pharma International Inc. has signed an...
BioSyent Schedules Q1 2016 Earnings Release for May 27, 2016
May 25, 2016 10:01 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - May 25, 2016) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) will be reporting its financial results for the three months ending March 31, 2016 on Friday,...
BioSyent Pharma Receives Health Canada Approval for New Urgent Care Product Using the Aguettant System(R)
May 05, 2016 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - May 5, 2016) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX)(OTC PINK:BIOYF) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has received...
BioSyent to Present at Upcoming Investor Conferences
April 06, 2016 14:07 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - April 6, 2016) - BioSyent Inc. ("BioSyent")(TSX VENTURE:RX)(OTC PINK:BIOYF) is pleased to announce that it will be presenting at the following upcoming...
BioSyent Releases Q4 and Full Year 2015 Results
March 04, 2016 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - March 4, 2016) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX)(OTC PINK:BIOYF) released today a summary of its financial results for the three and twelve...
BioSyent Schedules Fourth Quarter 2015 Earnings Release for March 4, 2016
February 12, 2016 17:45 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - Feb. 12, 2016) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX)(OTC PINK:BIOYF) will be reporting its financial results for the fourth quarter and fiscal...
BioSyent to Present at the LD Micro Main Event 2015 Investor Conference
November 30, 2015 09:56 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - Nov. 30, 2015) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that CEO René Goehrum will be making a presentation at the LD...
BioSyent Pharma Announces the Canadian Launch of CYSVIEW(R) (Hexaminolevulinate Hydrochloride)
November 17, 2015 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - Nov. 17, 2015) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today announced that its subsidiary BioSyent Pharma Inc. has commenced the Canadian launch of...
BioSyent Releases Results for Third Quarter and First Nine Months of 2015
November 11, 2015 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - Nov. 11, 2015) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) released today a summary of its financial results for the three and nine months ending...
BioSyent Named to the PROFIT 500 Ranking of Canada's Fastest-Growing Companies With a Five-Year Revenue Growth Rate of 1,086%
September 17, 2015 09:15 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - Sept. 17, 2015) -
Editors Note: There is a photo associated with this press release.
BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is...